Life Science

The Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and Forecasts, 4^th Edition (2024-2030) report by Kalorama Information explores the transformative potential of cell and gene therapies in modern medicine. These therapies offer groundbreaking treatments by addressing genetic causes of diseases and modulating the immune system. The report highlights the surge in new therapies and…

The 2024 SDi Global Assessment Datastream is only available to those who have purchased our The 2024 Global Assessment Report: The Analytical and Life Science Instrumentation Industry.

As life science researchers continue to elevate their expectations, understanding customer experience enables suppliers to identify areas of improvement and benchmark against their key competitors. In 2024, we continued a longitudinal study to support suppliers looking to improve their customer experience strategy. The outcome is our latest report, Benchmarking for 2024: Understanding the Life Science Customer…

Learn how your customers are using research antibodies! Designed to help suppliers of standard catalog antibodies, BioInformatics, part of Science and Medicine Group, initiated a study that asked 547 global life scientists about their usage and purchasing habits for research antibodies! This report, 2024 Market Report for Research Antibodies, will help commercial suppliers make strategic decisions about…

Discover Life Science customers’ expectations and perceptions of their experiences with customer service and technical support.

To help suppliers understand the importance of customer service and technical support in purchase decisions and recommendations of life science suppliers, BioInformatics, part of Science and Medicine Group, designed a study that asked 414 global life scientists with recent…

Kalorama Information’s Cell and Gene Therapy Deals Analysis: Financings, Partnering, M&A, Tech Transfers, IPOs/SPACs, Other Deals, 2021-2024 offers a comprehensive look at the dynamic and rapidly evolving cell and gene therapy market. This report highlights the significant deal-making activities that have taken place from Q1 2021 to Q1 2024, providing valuable insights for companies and…

Learn how to effectively inform and influence your life science customers with a comprehensive understanding of their digital media habits! 

To help suppliers develop their digital marketing strategies within the life sciences, we designed a study that asked 448 global life scientists about their usage of digital channels, their perceptions of the…

Explore the future of medicine with our in-depth report on cell therapy, gene therapy, and RNA therapy markets. Cell therapy and gene therapy represent a frontier in modern medicine, promising revolutionary treatments by treating the underlying genetic causes of disease and by genetically controlling the body’s immune system. Recent years have seen an increase in…

Learn how to effectively inform and influence your life science customers with a comprehensive understanding of their digital media habits!

To help suppliers develop their digital marketing strategies within the life sciences, we designed a study that asked 448 global life scientists about their usage of digital channels, their perceptions of the effectiveness of these…

The European market for analytical & life science instrumentation is evolving as regional and global factors influence its economies, policies, and funding. The years-long COVID-19 pandemic and its lingering effects upon the global supply chain have prompted numerous countries and the European Union to adopt policies that will safeguard supplies of essential therapeutics by on-shoring…

Explore the dynamic world of cell and gene therapy deal-making with Kalorama Information’s comprehensive report, Cell and Gene Therapy Funding and Deals Analysis: Financings, Partnering, M&A, Tech Transfers, IPOs/SPACs, Other Deals, 2021-2023. This report tracks the deal-making activities in cell and gene therapy since 2021, providing insightful graphs of quarterly trends from 2021-2023 and detailing…